Table 3.
Participant characteristics of all participants with data entered during the baseline phase
| Patient Characteristics | n=3615 (%) |
| Men | 2174 (60.1) |
| Age, yr, median (IQR) | 63.0 (50–73) |
| Ethnicity/ancestry | |
| Asian (including Chinese, Malay, Filipino, Vietnamese, and Indonesian) | 292 (8.1) |
| Indigenous Australian (including Aboriginal and Torres Strait Islander) | 350 (9.7) |
| White | 2331 (64.5) |
| Māori | 31 (0.9) |
| Pacific Islander (including Tongan, Samoan and Cook Islander) | 91 (2.5) |
| Other | 112 (3.1) |
| Medical records did not indicate ethnicity/ancestry | 408 (11.3) |
| State of enrolment | |
| ACT | 96 (2.7) |
| NSW | 1232 (34.1) |
| QLD | 877 (24.3) |
| NT | 194 (5.4) |
| SA | 245 (6.8) |
| VIC | 758 (21.1) |
| WA | 165 (4.6) |
| TAS | 48 (1.3) |
| Location of enrolling renal service | |
| Urban | 3111 (86.1) |
| Regional/rural | 504 (13.9) |
| Diabetes mellitus | |
| Yes, diet controlled | 309 (8.6%) |
| Yes, medication controlled | 1268 (35.1%) |
| Immunosuppressant use | 477 (13.2%) |
ACT, Australian Capital Territory; NSW, New South Wales; NT, Northern Territory; QLD, Queensland; SA, South Australia; TAS, Tasmania; VIC, Victoria; WA, Western Australia.